Final Monday, President Trump mentioned Tylenol is linked to autism. He was joined by well being officers — from left: Dr. Jay Bhattacharya, director of the Nationwide Institutes of Well being, Dr. Marty Makary, Meals and Drug Administration commissioner, Well being and Human Providers Secretary Robert F. Kennedy Jr., and Dr. Mehmet Oz, administrator of the Facilities for Medicare & Medicaid Providers.
Francis Chung/Politico/Bloomberg/Getty Photographs
disguise caption
toggle caption
Francis Chung/Politico/Bloomberg/Getty Photographs
President Trump’s announcement final week linking Tylenol with autism may play a task in ongoing authorized instances in opposition to the corporate that makes it.
One lawyer representing sufferers who say they have been harmed by the drug says his agency has gotten an inflow of greater than a thousand calls this week from potential new shoppers asking for data.
“A variety of inbound calls have are available, as you’ll anticipate now {that a} very vivid highlight has been placed on this problem,” says legal professional Ashley Keller, whose agency Keller Postman is representing folks in a product legal responsibility lawsuit in opposition to the drugmaker Kenvue.
The Trump administration’s consideration to the difficulty has additionally given the agency new ammunition in its attraction of the lawsuit, although the courts had successfully shot it down nearly two years in the past.
The president, flanked by federal well being officers, declared that acetaminophen, the generic title for Tylenol, “might be related to a really elevated threat of autism.”
Through the press convention, officers mentioned the Meals and Drug Administration would start the method of updating the protection label for Tylenol and acetaminophen.
“So taking Tylenol shouldn’t be good,” the president informed reporters. “All proper. I am going to say it. It is not good.” He went on to counsel that pregnant ladies may “robust it out” if they’ve a fever and mentioned there was “no draw back” to not taking the ache remedy.
A later press launch from the FDA was extra measured and famous that though some research discovered an “affiliation” between the painkiller and autism, they’d not established whether or not the painkiller in truth prompted autism. The press launch additionally mentioned that acetaminophen is the one secure over-the-counter ache remedy for pregnant ladies to take for fever, which might be dangerous for a creating fetus.
Keller says he filed what was among the many first lawsuits alleging that prenatal acetaminophen publicity prompted autism or ADHD. However in 2023, a decide dominated to exclude testimony from the consultants he and his colleagues had gathered to assist make their case. Decide Denise Cote of the Southern District of New York wrote that the consultants “cherry picked” and misinterpreted the info they have been counting on.
“I feel the decide’s different concern was that… the knowledgeable testimony was to assert that there was a causation, whereas the analysis itself by no means claims causation,” says Sonia Suter, a professor who teaches legislation and drugs on the George Washington College College of Legislation and was not concerned within the case. “So there was an inconsistency between the testimony for functions of being an knowledgeable witness and precisely what the findings of the research confirmed.”
However for the reason that Trump administration cited a kind of consultants, Dr. Andrea Baccarelli, of their announcement this week, Keller and his crew are submitting a brand new letter with the courtroom to assist their ongoing attraction.
“One factor that I feel is important is that his scientific evaluation was thought of dependable sufficient for our nation’s government department officers to credit score,” Keller says of Baccarelli. “And that is a fairly good signal that his scientific experience was reliably utilized. And in order that might be a related consideration for the Court docket of Appeals.”
The Harvard T.H. Chan College of Public Well being, the place Baccarelli is the dean, mentioned he is not out there for interviews.
Oral arguments within the attraction start on Oct. 6, Keller says.
Nonetheless, authorized consultants aren’t so certain the administration’s announcement will make a lot distinction to a decide as a result of there isn’t any new information.
“I do not suppose it implies that they’ve a greater probability,” says Dr. Aaron Kesselheima professor of drugs at Brigham and Girls’s Hospital and Harvard Medical College, the place he created the Program on Regulation, Therapeutics and Legislation. “Nothing basically has modified concerning the analysis. The science is similar immediately because it was final week and earlier than all this nonsense.”
Product legal responsibility instances are robust to show, he says. In the end, legal professionals should show causation, which hasn’t but been established.
Nonetheless, that does not imply it will not trigger a giant headache for Tylenol’s producer, Kenvue, which spun off from Johnson & Johnson in 2023.
“I feel there’s one thing very harmful concerning the president utilizing his energy to make statements that aren’t supported within the science,” says Suter. “I feel that may be very harmful for public well being usually.”
As for Kenvue, it issued an announcement saying it disagrees with any suggestion that taking acetaminophen causes autism, as a result of a long time of scientific analysis present that it’s secure. The assertion went on to notice that “excessive fevers and ache are well known as potential dangers to a being pregnant if left untreated.”
